‘Dangling’ Accelerated Approval Reviews Expand At US FDA
• By Michael McCaughan
US FDA's oncology center is starting to look at a wider array of accelerated approvals as it continues to consider 'dangling' indications. • Source: Alamy
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
